## Abstract Objectives: The goal of this study was to evaluate the safety and efficacy of nicardipine in reversing noβreflow during percutaneous coronary intervention (PCI). Background: Noβreflow is a common complication of PCI in patients with acute coronary syndromes or venous bypass graft diseas
Resolution of refractory no-reflow with intracoronary epinephrine
β Scribed by Kimberly A. Skelding; James A. Goldstein; Laxmi Mehta; Mark C. Pica; William W. O'Neill
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 76 KB
- Volume
- 57
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Slow or no reflow is a serious problem complicating catheter-based revascularization of degenerated saphenous vein bypass grafts. We examined the efficacy of rapidly delivered, high-velocity injections of intracoronary adenosine to reverse 11 slow-flow events complicating stenting of diseased bypass
No-reflow has been repo~ed after 1&15% of percutaneous interventlons on degenerated saphenous veln grafts. in this prospective study of 36 degenerated saphenous veln graft lesions (32 patlents), no-reflow (TIMI flow <3 in the absence of a significant lesion or dissectlon) occurred in 15/36 (42%) les